A detailed history of Pavion Blue Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Pavion Blue Capital, LLC holds 8,999 shares of PFE stock, worth $240,453. This represents 0.12% of its overall portfolio holdings.

Number of Shares
8,999
Holding current value
$240,453
% of portfolio
0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$27.7 - $31.39 $249,272 - $282,478
8,999 New
8,999 $260,000
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $56,179 - $72,971
-2,150 Reduced 23.53%
6,987 $201,000
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $8,600 - $10,052
268 Added 3.02%
9,137 $303,000
Q2 2023

Aug 02, 2023

SELL
$36.12 - $41.79 $97,524 - $112,833
-2,700 Reduced 23.34%
8,869 $325,000
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $11,817 - $15,384
-300 Reduced 2.53%
11,569 $472,000
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $23,380 - $30,520
560 Added 4.95%
11,869 $608,000
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $26,901 - $33,333
588 Added 5.48%
11,309 $585,000
Q4 2021

Jan 26, 2022

SELL
$41.32 - $61.25 $8,264 - $12,250
-200 Reduced 1.83%
10,721 $633,000
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $5,781 - $6,549
-161 Reduced 1.45%
10,921 $428,000
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $31,763 - $40,389
-949 Reduced 7.89%
11,082 $408,000
Q3 2020

Nov 02, 2020

BUY
$31.75 - $37.25 $29,908 - $35,089
942 Added 8.49%
12,031 $442,000
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $44,276 - $53,713
1,470 Added 15.28%
11,089 $363,000
Q1 2020

May 11, 2020

BUY
$27.03 - $38.62 $260,001 - $371,485
9,619 New
9,619 $314,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pavion Blue Capital, LLC Portfolio

Follow Pavion Blue Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pavion Blue Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pavion Blue Capital, LLC with notifications on news.